pharma · Hematologic Malignancies · Solid Tumor, Adult
Farmatek
Zafatek
Farmatek patent portfolio — 53 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Aydınlı - KOSB Mah. Tuzla Kimya Sanayicileri Org. San. Böl. Analitik Cad. No:90 Tuzla, Istanbul, TR, JP
- Founded
- 1994
- Employees
- 14
- Programs
- 26
- Drugs
- 14
- Patents
- 53
Farmatek patents
53 pharmaceutical patents indexed for Farmatek. 0 expire within 24 months.
Farmatek has 53 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 8993633
Treatment of muscle disease characterized by insulin resistance
granted -
US 6468959
Peroral dosage form for peptide containing medicaments, in particular insulin
expired -
US 6103269
Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
expired -
US 6068854
Sol-controlled thermocolloid matrix based on gelatin for oral sustained-release form
expired -
US 6066332
Immediate-effect ibuprofen-containing medicament and its use
expired
Frequently asked questions
How many patents does Farmatek have?
53 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Farmatek patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.